Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Treponema test, Vaccination site pain
Clinical narrative: Maternal exposure during pregnancy; tired; soreness at injection site; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) and FATIGUE (tired) in a 35-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 031A21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: ALCOHOL (1-2 drinks, 3 x week) in 2001 and MARIJUANA (on occasion) from 2002 to 2015. Concomitant products included MAGNESIUM (MAGNESIUM 6) for Pregnancy, ONDANSETRON and DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (DICLEGIS) for Vomiting, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] from 03-Aug-2020 to an unknown date for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. The patient's last menstrual period was on 31-Aug-2020 and the estimated date of delivery was 27-May-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) and FATIGUE (tired). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fifth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved and FATIGUE (tired) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2020, Pregnancy test: positive (Positive) positive. On 03-Mar-2021, Glucose tolerance test: normal (normal) normal. On 03-Mar-2021, Treponema test: normal (normal) normal. On 03-Dec-2021, Alpha 1 foetoprotein: normal (normal) normal. On an unknown date, Full blood count: normal (normal) normal. On an unknown date, HIV test negative: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On an unknown date Ultrasound scan, genetic testing, and Chromosome 13+18+21+x+y+aneuploidy  was done and reports were found to be  normal.  Patient  used to smoke 2packs cigarettes/week 6times/week.  Treatment information not provided. On 10 Nov 2017 patient had previous delivery wherein in patient gave birth to one fetus who was born Live with full-term birth. The Gestation Period of current pregnancy was 25 weeks.   This case was linked to MOD-2021-124845 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: AE dose 1, Reporter address, HCP information, Preg. hx, Preg. exams, Preg. products.